Why Physicians Are Optimistic about Newly Diagnosed Myeloma image

Why Physicians Are Optimistic about Newly Diagnosed Myeloma

Feb 18, 2021
11:00AM - 12:00PM MST
Online Event
Overview
Fear, uncertainty, and pessimism accompany virtually every cancer diagnosis, especially if most patients, like those with myeloma, have never even heard the word before. Yet myeloma specialists are increasingly confident and optimistic that the vast majority of diagnosed patients have legitimate paths toward longevity, good quality of life, and will benefit from increasing treatment options and experience. Join us as we review the Myeloma Crowd Round Table featuring Multiple Myeloma Specialists. After we review the MCRT, Dr. Sarah Lee will serve as our moderator for a Q&A. Come with questions! This is a Google Meet Meeting. You can join even if you don't have a Gmail Account. If you are joining via mobile, please make sure you have the Google Meet App downloaded.
Agenda
11:00 AM
Introductions
Audrey Burton-Bethke
Audrey Burton-Bethke, Manager of the Myeloma Community, introduces the agenda of the event and Dr. Sarah Lee who will moderate our Q&A. 
11:05 AM
Presentation: Why Physicians are Optimistic about Newly Diagnosed Myeloma
Myeloma Crowd Round Table
Watch portions of the Myeloma Crowd Round Table session and hear from multiple myeloma specialists about why they are optimistic about newly diagnosed myeloma. 
11:35 AM
Questions and Answers
Sarah Lee, MD
Dr. Sarah Lee will moderate our Q&A. What questions did the MCRT spark for you? What other questions do you have? 
Speakers & Moderators
Healthtree contact Audrey Burton-Bethke

Audrey Burton-Bethke

Audrey joined the Myeloma Crowd as the Community Manager in 2020 after previously working in the nonprofit field for 4 years as a director of Fundraising and Development. She graduated from BYU with a major in Spanish and Nonprofit Management. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.
Healthtree contact Sarah Lee, MD

Sarah Lee, MD

Sarah Lee, M.D., long dreamed of being a physician, simply because she wanted to help people. She guides her patients in navigating the challenges of treatment, putting a priority on being an active listener. That way, she can understand patients’ goals and empower them to make informed decisions about their treatment. Dr. Lee is an oncologist/hematologist specializing in plasma-cell disorders such as myeloma and amyloidosis. By the time she joined City of Hope in 2023, she had co-authored 12 peer-reviewed biomedical publications and was site principal investigator for seven active clinical trials. She was previously on the faculty at Fred Hutchinson Cancer Research Center. Before medical school, she served as a clinical research coordinator at a cancer center. Dr. Lee has earned such honors as the Merit Award from the American Society for Clinical Oncology's Conquer Cancer Foundation and an appointment as chief quality improvement fellow during her training at Cleveland Clinic. Her pastimes include enjoying the outdoors with her two rescue pups, spending time with family and friends, and traveling.